South African-based NTP Radioisotopes recently incurred its own shutdown in November due to a suspected hydrogen leak, opening once more last month and relieving fears over a shortage in Mo-99 supplies.

Such concerns have instilled competitiveness among many healthcare players, such as between Shine Medical Technologies Inc., which just completed the first building of its medical isotope production facility, and NorthStar, which recently received FDA clearance for its RadioGenix system for Mo-99 production. The two are vying to be the first domestic source of the radioisotope in the U.S. in more than 25 years.


Founding members of the CNIC council include the Brain Tumour Foundation of Canada; Bruce Power; Framatome; Nordion; the Canadian Nuclear Association; SNC-Lavalin; Canadian Nuclear Laboratories; the International Irradiation Association; the Ontario Association of Nuclear Medicine; BWXT; Isotopen Technologien; Ontario Power Generation; Cameco; CanProbe; Laker Energy; the Organization of Canadian Nuclear Industries; the Canadian Association of Nuclear Medicine; the Centre for Probe Development and Commercialization; and NB Power.

Back to HCB News

Molecular Imaging Homepage